Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.

To establish a baseline for care and overall survival (OS) based upon contemporary first-line treatments prescribed in the era before the introduction of immune checkpoint inhibitors, for people with metastatic non-small cell lung cancer (NSCLC) without common actionable mutations.Using a nationally...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Amy P Abernethy, Ashwini Arunachalam, Thomas Burke, Caroline McKay, Xiting Cao, Rachael Sorg, David P Carbone
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science (PLoS) 2017-01-01
Serie:PLoS ONE
Länkar:http://europepmc.org/articles/PMC5482433?pdf=render
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk